4.57
0.12 (2.7%)
0.12 (2.7%)
Upgrade to Real-Time
Regular Market
Low
2.8149
High
9.00
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BriaCell Therapeutics Corporation | BCTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.12 | 2.7% | 4.57 | 13:45:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.40 | 4.40 | 4.89 | 4.45 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.57 | 4.62 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,577 | 515,801 | $ 4.68 | $ 2,415,663 | - | 2.8149 - 9.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:46:21 | 2 | $ 4.595 | USD |
Period:
Draw Mode:
BriaCell Therapeutics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 69.51M | 15.21M | 15.21M | $ - | $ - | - | -4.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
BriaCell Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.76 | 4.89 | 4.25 | 4.50 | 684,898 | -0.19 | -3.99% |
| 1 Month | 5.50 | 6.80 | 4.25 | 5.40 | 2,043,760 | -0.93 | -16.91% |
| 3 Months | 3.90 | 9.00 | 2.82 | 5.93 | 4,441,377 | 0.67 | 17.18% |
| 6 Months | 4.24 | 9.00 | 2.8149 | 5.53 | 3,015,985 | 0.33 | 7.78% |
| 1 Year | 4.24 | 9.00 | 2.8149 | 5.53 | 3,015,985 | 0.33 | 7.78% |
| 3 Years | 4.24 | 9.00 | 2.8149 | 5.53 | 3,015,985 | 0.33 | 7.78% |
| 5 Years | 4.24 | 9.00 | 2.8149 | 5.53 | 3,015,985 | 0.33 | 7.78% |
BriaCell Therapeutics Description
| BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies. |
